FDA Investigator Lareese K Thomas

Lareese K Thomas has conducted inspections on 92 sites in 5 countries as of 31 Jul 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
92
Last Inspection Date:
31 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
100009249
Countries of Inspections:
United States of America, Spain, China, India, Puerto Rico
FDA Investigators that have inspected at least one site in common with Lareese K Thomas:
Aaron P Wozniak, Adam R Cooke, Aditi S Thakur, Alexis S Roberts, Amanda L Evanco, Ana L Kewes, Andrea L Williams Jones, Ann B Borromeo, Anthony S Puckett, April R Bowen, Ariel Cruz Figueroa, Arlene M Badillo, Arthur G Hurst, Babatunde D Babalola, Betsy C Galliher, Bonita S Chester, Brandon C Heitmeier, Brandy D Brown, Brenda Rivera, Calvin Foulks, Carolyn W White, CDR Ileana Barreto Pettit, Chateryl K Washington, Christie B Rice, Christine M O'leary, Christopher C Wilcox, Christopher S Keating, Claudette D Brooks, Clinton V Giustra, Constance Y Fears, Crystal A Harlan, D Ross Spears, PhD, Daniel L Obrzut, Darryl T Newell, David T Glover, David Williams, Deborah A Greco, Dellarese L Herbert, Denise M Digiulio, Derek C Price, Diane P Goyette, Dorothy P Kramer, Edward Deberry, Edwin Martinez, Eileen J Bannerman, Frederick F Razzaghi, Gabriel R Mclemore, George J Flynn, German Rivera, Gideon N Esuzor, Hai Lient Phung, Ibad U Khan, Ingrid A Zambrana, J'maica J Hunter, Jamie L Port, Janet B Gray, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeffrey D Sheppard, Jennifer Lalama, Jessica Fields, Jessica M Simpson, PhD, Jill J Tillman, Jimmy O Buford, John D Lloyd, Johnetta F Walters, Jorge L Guadalupe, Jose A Lopez, José E Meléndez, Jose M Cayuela, Joseph F Owens, Justin A Boyd, Kara D Dobbin, Kathryn A Nagy, Katrina B Mosley Sloan, Kebire G Abraha, Kenny R Robinson, Keri U Walker, Kerry L Edwards, III, Kevin T Nguyen, Kham Phommachanh, Kip J Hanks, Krishna Ghosh, PhD, Kshitij A Patkar, Kunapuli T Madhusudhan, Larry K Hampton, Laurimer Kuilan Torres, Lawrence Thomas, Leah M Andrews, Leon L Crawley, Leslie W Gilbert, Libia M Lugo, Liming Zhang, Lisa L Flores, LT Richard A Lyght, LT Tamara J Henderson, Marcella D Crook, Margaret M Annes, Marian E Ramirez, Marianela Aponte Cruz, Marie F Morin, Marvin D Jones, Matthew G Brown, Mcbean, Miaja Umaedi, Michelle D Haamid, Myla D Chapman, Myoshi M Francis, Myriam M Sosa, N'jere English, Nancy E Fontaine, Nancy E Ford, Nicholas Z Lu, Nicole A Lloyd, Nicole M Bell, Nigel L Hirth, Noreen Muñiz, Patricia F Hudson, Paul W Moy, Penny H Mccarver, Pratik S Upadhyay, DDC, Rachael L Cook, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rashonda N Rucker, Reba A Gates, Rebecca Parrilla, Regan T Harp, Richard L Garcia, Richard Lyght, Robert L Lewis, Jr, Robert P Neligan, Robert Q Green, Robin N Goins, Saeid E Kazan, Samantha E Cleek, Samantha J Bradley, Samina S Khan, Sandra I Gaul, Sandra R Saunders, Satheesh Thomas, Saundrea A Munroe, Sayeeda Hdabe, Seneca D Toms, Sereen Gmorgan Murray, Sharna D Pratt, Shelby N Turner, Sheri S Oliver, Simone M Edmonson, Song Y Lavalais, Sonya M Edmonds, Stephanie E Hubbard, Steven A Brettler, Steven D Dittert, Susan M Taylor, Susan O Oladeji, Tamika D Cathey, Theresa L Stewart, Thomas J Arista, Tomika L Bivens, Traci M Armand, Tracy R Ball, Trang N Cox, Tyrico K English, Vanessa E Coulter, Veronica Fuentes, MS, Victoria L Palmer, Vilmary Negron Rodriguez, Vincent M Williams, Vincent Thomas, Viviana Matta, Wayne S Fortenberry, William P Tonkins, Yifan Wang, Ying Zhang, Young Kim, Zada L Giles

Lareese K Thomas's Documents

Publish Date Document Type Title
August, 2010 FDA 483 Moustafa A. Moustafa, M.D. - Form 483, 2010-08-13
April, 2013 FDA 483 Clinical Specialties Compounding Pharmacy - Form 483, 2013-04-02
April, 2012 EIR O'Barr, Thomas MD - EIR, 2012-04-30
October, 2013 FDA 483 Daniel Shapiro - Form 483, 2013-10-21
February, 2022 FDA 483 Response Lilly del Caribe, Inc. - Form 483R, 2022-03-18
April, 2010 EIR Acella Pharmaceuticals, LLC - EIR, 2010-04-02
March, 2023 EIR Eli Lilly and Company - EIR, 2023-03-16
June, 2013 FDA 483 Medi-Fare Drug - Form 483, 2013-06-21
February, 2012 EIR Hi-Tech Pharmaceuticals Inc. - EIR, 2012-02-29
July, 2012 FDA 483 Attalla, Ashraf, M.D. - Form 483, 2012-07-13
April, 2012 FDA 483 O'Barr, Thomas MD - Form 483, 2012-04-30
March, 2010 FDA 483 Newton Laboratories Inc - Form 483, 2010-03-11
September, 2010 FDA 483 Hanna Khoury - Form 483, 2010-09-30
April, 2010 FDA 483 Acella Pharmaceuticals, LLC - Form 483, 2010-04-02
February, 2022 FDA 483 Lilly del Caribe, Inc. - Form 483, 2022-02-25
June, 2012 FDA 483 V-SAB Medical Labs, Inc. - Form 483, 2012-06-22
November, 2012 FDA 483 Halocarbon Life Sciences, LLC - Form 483, 2012-11-02
April, 2018 EIR SMS LIFESCIENCES INDIA LIMITED - EIR, 2024-01-16
September, 2012 FDA 483 PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma - Form 483, 2012-09-13
June, 2023 FDA 483 Delta Pharma, Inc. - Form 483, 2023-06-02
February, 2022 EIR Lilly del Caribe, Inc. - EIR, 2022-04-13
June, 2010 EIR Robert M. Strauss, MD - EIR, 2010-06-04
June, 2012 EIR Symrise, Inc. - EIR, 2012-06-20
February, 2012 FDA 483 Shionogi Inc. - Form 483, 2012-02-08
April, 2012 FDA 483 Hanna Khoury - Form 483, 2012-04-03
January, 2020 EIR LSNE-LEON SLU - EIR, 2020-01-17
January, 2010 FDA 483 Abc Compounding Company Inc - Form 483, 2010-01-07
February, 2015 FDA 483 Health Innovations Pharmacy, Inc - Form 483, 2015-02-27
September, 2009 FDA 483 Perfecto Products Mfg Inc - Form 483, 2009-09-10
October, 2010 FDA 483 Alexander, Elmore - Form 483, 2010-10-20
December, 2018 FDA 483 Impact Fulfillment Services - Form 483, 2018-12-19
February, 2012 EIR Hi-Tech Nutraceuticals,LLC - EIR, 2012-02-28
November, 2012 EIR Halocarbon Life Sciences, LLC - EIR, 2012-11-02
February, 2012 EIR Brian Bortnick - EIR, 2012-02-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more